Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team
Press release

BioStock: Saniona-backed Cephagenix secures 9 MEUR in seed financing

Saniona

Saniona has announced that Cephagenix, a joint venture with Professor Jes Olesen at the University of Copenhagen, has successfully raised up to 9 MEUR  in tranched seed financing. The funding round was led by AdBio Partners and AbbVie Ventures and aims to accelerate the development of Cephagenix's vascular KATP channel inhibitor program, targeting novel anti-migraine therapies. BioStock reached out to Saniona's CEO Thomas Feldthus for a comment.

Read the interview with Thomas Feldthus at biostock.se:

https://www.biostock.se/en/2025/01/saniona-backed-cephagenix-secures-9-meur-in-seed-financing/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.